ADDF's 11th International Conference on Alzheimer's Drug Discovery

HOME | PROGRAM | SPEAKERS | SCHOLARSHIPS | REGISTRATION | ACCOMMODATIONS | SPONSORSHIP | SUPPORTERS | CONTACT

The 11th International Conference on Alzheimer's Disease Drug Discovery is presented by the Alzheimer's Drug Discovery Foundation (ADDF), the only public charity solely dedicated to rapidly accelerating the discovery and development of drugs to prevent, treat and cure Alzheimer's disease and cognitive aging. This conference will bring together academic and industry scientists to accelerate the development of innovative treatments for Alzheimer’s disease and related dementias. Speakers will present their current research, provide updates and stimulate discussion among attendees.
CONFERENCE OBJECTIVES	TARGET AUDIENCE	2010 SCHOLARSHIPS	EXHIBIT/SPONSORSHIP	PAST PROGRAMS
The objectives of the conference are: Highlight scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias. Increase networking opportunities for scientists to share information and resources. Foster interdisciplinary and public-private partnerships and alliances. .	The 2009 edition of this conference attracted attendees from around the globe. Attendees included: Academic and industry scientists engaged in drug discovery research for neurodegenerative diseases or CNS Business development and licensing professionals Alliance management professionals Venture capitalists and other investors.	The Alzheimer’s Drug Discovery Foundation invites applications for the 2010 ADDF Young Investigator Scholarships. Click here to review the list of winners.	The 11^th International Conference on Alzheimer’s Disease Drug Discovery offers a great opportunity to expand your company's visibility among the registrants by becoming a conference sponsor and/or exhibitor. Review the ample options and contact us today!	2009 PROGRAM 2008 PROGRAM Click here to read the 2009 conference summary authored by Dr. Diana Shineman, ADDF's Director of Scientific Affairs. Review also ADDF's "sister" conference on neurodegenerative diseases. All links in this column will open new windows.